Gath I, Weidenfeld J, Collins G I, Hadad H
Br J Clin Pharmacol. 1984 Oct;18(4):541-7. doi: 10.1111/j.1365-2125.1984.tb02502.x.
The comparative action of two specific benzodiazepine antagonists, Ro 15-1788 and Ro 15-3505 was examined in six healthy volunteers. Medication was given i.v. in a double-blind cross over pattern, and EEG was recorded throughout each experimental session. Ten minutes after the injection of one of the antagonists or placebo, midazolam was injected in incremental doses until first signs of drowsiness appeared in the EEG. The EEG was computer analyzed, using adaptive segmentation and time-dependent clustering. Continuous power profiles for various frequency bands, as well as power ratios for the physiological frequency bands (e.g. sigma/alpha power ratio) were generated. It has been found that sigma/alpha power ratio was the most sensitive parameter detecting early effects of midazolam on the EEG signal, thus enabling a semi-quantitative titration of the antagonists by midazolam. Ro 15-1788 in doses of 5 mg i.v. was counteracted on average by 7.3 mg midazolam. From the EEG analysis it has been found that Ro 15-3505 was at least 4-5 times more potent than Ro 15-1788.
在六名健康志愿者身上研究了两种特异性苯二氮䓬拮抗剂Ro 15 - 1788和Ro 15 - 3505的对比作用。药物通过静脉注射,采用双盲交叉模式给药,并且在每个实验过程中全程记录脑电图。在注射其中一种拮抗剂或安慰剂十分钟后,以递增剂量注射咪达唑仑,直到脑电图中出现嗜睡的最初迹象。使用自适应分割和时间依赖性聚类对脑电图进行计算机分析。生成了各个频段的连续功率分布图以及生理频段的功率比(例如西格玛/阿尔法功率比)。已发现西格玛/阿尔法功率比是检测咪达唑仑对脑电图信号早期影响的最敏感参数,从而能够通过咪达唑仑对拮抗剂进行半定量滴定。静脉注射5毫克的Ro 15 - 1788平均被7.3毫克咪达唑仑抵消。从脑电图分析发现,Ro 15 - 3505的效力至少比Ro 15 - 1788强4至5倍。